CONLEY SHERYL L 4

What Happened

• Sheryl L. Conley, a director of Anika Therapeutics (ANIK), received a grant of 10,402 restricted stock units (RSUs) on 2026-06-18. The reported per‑share price is $0.00 for a reported total value of $0 (this reflects an award, not a purchase).
• The RSUs are a contingent right to receive one share of common stock per RSU upon vesting.

Key Details

• Transaction date: 2026-06-18; Form 4 filed: 2026-06-23.
• Transaction type: Award/Grant (code A); 10,402 RSUs granted at $0.00.
• Vesting: RSUs vest in full on the earlier of the Company’s 2027 annual meeting or June 18, 2027 (per filing footnote).
• Shares owned after the transaction: not disclosed in the provided filing excerpt.
• No tax‑withholding or sale/transfer reported in this filing.
• Filing timing: the Form 4 was filed five days after the grant date (normally Form 4s are due within two business days), so this filing appears to be late.

Context

• RSU grants are compensation awards that convert to shares only upon vesting; they do not represent an immediate purchase or sale and don't necessarily indicate buying/selling sentiment.
• For retail investors, awards to directors are common and part of compensation programs; they increase potential future share dilution when they vest and are settled.